TritonisQualified suppliers · landed cost in Canada
HS code 300331 · Canadian Customs Tariff, T2026-2 edition

Canadian customs duties: Insulin-based medicaments (HS 300331)

Illustration: Insulin-based medicaments

Pharmaceutical products › Multi-constituent bulk medicaments

Official HS description 300331: Medicaments; containing insulin, for therapeutic or prophylactic uses, not packaged for retail sale

General rate (MFN) 0%0% from all origins
Made in Canadano customs duty
Read the full explanation

Canada's Customs Tariff has 1 tariff item for this product (HS 300331). Most-Favoured-Nation (MFN) rate: 0%. Preferential rates: Commonwealth Caribbean Countries Tariff 0%, CETA (European Union) 0%, Canada-Israel FTA 0%, Canada-Colombia FTA 0%, CPTPP 0% and CPTPP (United Kingdom) 0%. Tariff T2026-2, in force since September 1, 2026.

The customs duty depends on the goods' country of origin and on Canada's free-trade agreements. Goods of Canadian origin pay none; goods from a partner country may be exempt; others pay the Most-Favoured-Nation (MFN) rate. Surtaxes in force and cautions (sanctions, forced labour) are shown.

No supplier page has been published for this product yet. Search for it: we will help you find suppliers. Search

Calculate the landed cost in Canada

The duty rate isn't the whole story: enter your order's value and origin to see the duties, surtax and taxes payable on import.

If a freight forwarder has already given you a price, enter it: it is counted in the landed cost of the chosen origin.

Canadian import duty by country of origin

Canadian import duty by country of origin
OriginDutyTreatmentSurtax
Canada CA 0 % (made in Canada)
United States US 0%
MFN
Netherlands NL 0%
MFN
Germany DE 0%
MFN
India IN 0%
MFN
Austria AT 0%
MFN
France FR 0%
MFN
Morocco MA 0%
MFN
Denmark DK 0%
MFN
New Zealand NZ 0%
MFN
Hungary HU 0%
MFN

Source: CBSA, Customs Tariff, T2026-2 edition, in force since . https://www.cbsa-asfc.gc.ca/trade-commerce/tariff-tarif/

Contains information licensed under the Open Government Licence – Canada. https://open.canada.ca/en/open-government-licence-canada

For information only: preferential treatment requires meeting the agreement's rules of origin. This does not replace advice from a licensed customs broker.

Customs Tariff descriptions

Customs Tariff descriptions — HS 300331
Tariff itemOfficial descriptionMFNPreferential rates
3003.31.00Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. - Other, containing hormones or other products of heading 29.37: - Containing insulinFreeCCCT, LDCT, GPT, UST, MXT, CIAT, CT, CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, KRT, CEUT, UAT, CPTPT, UKT, CPUKT: Free

How to read this table

The duty applies to the customs value of the goods. The “MFN” rate is the general rate; preferential treatments require proof of origin. Specific rates (per kilogram, per unit) are written as published. Data comes from the Customs Tariff published by the CBSA; confirm your product's exact tariff classification with a customs broker.

Frequently asked questions

What is the Canadian customs duty on insulin-based medicaments?

The general rate (most-favoured-nation, MFN) is 0% for HS code 300331. The product enters Canada duty-free at the general rate. Source: Customs Tariff, edition T2026-2; the comparator on this page details each origin, surtaxes included.

What is the lowest Canadian customs duty on imports of insulin-based medicaments?

Under Canada's Customs Tariff, the lowest duty among the origins compared is 0%, for goods from the United States (MFN), from the Netherlands (MFN) and from Germany (MFN). Source: Customs Tariff, edition T2026-2; the comparator on this page details each origin, surtaxes included.

Is a surtax charged on imports of insulin-based medicaments?

No surtax applies to the origins compared on this page.